Menstrually related worsening of symptoms in multiple sclerosis

Journal of the Neurological Sciences
Anneke Zorgdrager, Jacques De Keyser

Abstract

The objective of this study was to investigate whether the menstrual cycle influences multiple sclerosis (MS) symptoms. Seventy-two normally menstruating women (aged 20-50 years) with MS were interviewed. Of the 60 patients with a relapsing-remitting form of MS (RR-MS), 26 (43%) regularly experienced worsening of their MS symptoms in the period just before, or at the beginning of, the menstruation. Significantly more patients of the group reporting no influence of the premenstrual period on MS symptoms were using an oral contraceptive (p=0.041), suggesting a protective effect. There were 12 patients with the primary chronic progressive form of MS (PCP-MS). None of them experienced an influence of the menstrual cycle on their symptoms. Our results suggest that hormonal changes preceding menstruation may worsen symptoms in a subgroup of women with RR-MS.

References

Jan 1, 1992·Pediatric Neurology·M J Schwabe, R J Konkol
Feb 1, 1991·The Journal of Clinical Endocrinology and Metabolism·F PetragliaG Grasso
Jan 1, 1985·The International Journal of Biochemistry·S Tsakiris, G Deliconstantinos
Dec 1, 1984·Cephalalgia : an International Journal of Headache·K M WelchR T Simkins
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Feb 1, 1993·Contraception·L Villard-Mackintosh, M P Vessey

❮ Previous
Next ❯

Citations

May 10, 2005·Journal of the Neurological Sciences·Martine El-EtrChristian Confavreux
Apr 11, 2003·Journal of the Neurological Sciences·Linh T NguyenLawrence D Jacobs
Dec 18, 2001·Brain Research. Brain Research Reviews·M SchumacherE E Baulieu
Nov 24, 1999·Journal of Cataract and Refractive Surgery·P Pivetti-PezziF B Pantaleoni
Apr 12, 2002·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Richard S Shames
Oct 1, 2010·Continuum : Lifelong Learning in Neurology·Elizabeth Crabtree-Hartman
Nov 26, 2014·European Journal of Endocrinology·Simona GaberščekElisabeth Lerchbaum
May 12, 2009·Journal of the Neurological Sciences·V Tomassini, C Pozzilli
Jul 22, 2015·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Per KempeJan Brynhildsen
Apr 9, 2011·Journal of Neuroimmunology·Judith M Greer, Pamela A McCombe
Apr 26, 2006·Expert Opinion on Pharmacotherapy·Valentina Tomassini, Carlo Pozzilli
Jul 4, 2015·Neurology. Neuroimmunology and Neuroinflammation·Carlo PozzilliPatrizia Pantano
Apr 19, 2016·American Journal of Human Biology : the Official Journal of the Human Biology Council·Judyta NowakBoguslaw Pawlowski
Nov 15, 2011·Journal of Autoimmunity·Olga L QuinteroJuan-Manuel Anaya
Apr 18, 2015·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Hanna CharbitIris Lavon
Jul 28, 2016·Contraception·Lauren B ZapataKathryn M Curtis
Mar 17, 2010·Medical Hypotheses·Helmut Leitner
Nov 18, 2009·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Per HolmqvistJan Brynhildsen
Jun 27, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Pamela A McCombe, Judith M Greer
Jul 28, 2005·Journal of Neuroimmunology·Clara M PelfreyRichard A Rudick
Sep 1, 2003·Expert Review of Neurotherapeutics·Pamela A McCombe
Aug 14, 2001·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·R R Voskuhl, K Palaszynski
Jul 8, 2017·The Journal of Comparative Neurology·Lisa M DiCarloRichard S Nowakowski
Jan 4, 2012·Neurologia i neurochirurgia polska·Beata Zakrzewska-PniewskaMonika Nojszewska
Feb 17, 2010·Nature Reviews. Neurology·Adam E HandelSreeram V Ramagopalan
Jan 31, 2007·Annals of the New York Academy of Sciences·Silvia PozziElisabetta Vegeto
May 29, 2008·Expert Review of Neurotherapeutics·Angelo Ghezzi, Mauro Zaffaroni
Apr 27, 2013·American Journal of Physical Medicine & Rehabilitation·Chetan P PhadkeChris Boulias
Oct 8, 1998·Multiple Sclerosis : Clinical and Laboratory Research·A T RederA M Porrini
May 1, 2018·Neurology. Clinical Practice·Marwa KaiseyBarbara Giesser
Jun 13, 2003·The Neurologist·Barbara S Giesser
Nov 22, 2016·Journal of Neuroscience Research·Lisa C Golden, Rhonda Voskuhl
Jun 17, 2005·Multiple Sclerosis : Clinical and Laboratory Research·Hans H L P van den BroekRaymond M M Hupperts
Dec 9, 2020·American Journal of Human Biology : the Official Journal of the Human Biology Council·Tara J Cepon-Robins

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.